BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Burtin C, Bezuidenhout J, Sanders KJC, Dingemans AC, Schols AMWJ, Peeters STH, Spruit MA, De Ruysscher DKM. Handgrip weakness, low fat-free mass, and overall survival in non-small cell lung cancer treated with curative-intent radiotherapy. J Cachexia Sarcopenia Muscle 2020;11:424-31. [PMID: 32045108 DOI: 10.1002/jcsm.12526] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Migdanis I, Gioulbasanis I, Migdanis A, Armeni E, Sgantzos M, Kapsoritakis A, Kontogianni MD. Objective Measurements of Physical Function to Predict Survival in Patients with Metastatic Cancer. Nutr Cancer 2023;75:912-22. [PMID: 36688336 DOI: 10.1080/01635581.2023.2170429] [Reference Citation Analysis]
2 Song M, Zhang Q, Song C, Liu T, Zhang X, Ruan G, Tang M, Xie H, Zhang H, Ge Y, Li X, Zhang K, Yang M, Li Q, Liu X, Lin S, Xu Y, Xu H, Wang K, Li W, Shi H. The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer. J Cachexia Sarcopenia Muscle 2022;13:2504-14. [PMID: 35833264 DOI: 10.1002/jcsm.13032] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Ge YZ, Ruan GT, Zhang Q, Dong WJ, Zhang X, Song MM, Zhang XW, Li XR, Zhang KP, Tang M, Li W, Shen X, Shi HP; Investigation on the Nutrition Status and Clinical Outcome of Common Cancers (INSCOC) Group. Extracellular water to total body water ratio predicts survival in cancer patients with sarcopenia: a multi-center cohort study. Nutr Metab (Lond) 2022;19:34. [PMID: 35525966 DOI: 10.1186/s12986-022-00667-3] [Reference Citation Analysis]
4 Xie H, Ruan G, Zhang Q, Ge Y, Song M, Zhang X, Liu X, Shiqi L, Zhang X, Li X, Zhang K, Yang M, Tang M, Cong M, Shi H. Combination of Nutritional Risk Index and Handgrip Strength on the Survival of Patients with Cancer Cachexia: A Multi- Center Cohort Study. JIR 2022;Volume 15:1005-15. [DOI: 10.2147/jir.s352250] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Cortiula F, Hendriks LEL, van de Worp WRPH, Schols AMWJ, Vaes RDW, Langen RCJ, De Ruysscher D. Physical exercise at the crossroad between muscle wasting and the immune system: implications for lung cancer cachexia. J Cachexia Sarcopenia Muscle 2022;13:55-67. [PMID: 35014216 DOI: 10.1002/jcsm.12900] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Fukushima T. The Effect of Physical Exercise on Physical Function and Survival Rate in Cancer Patients. Physical Therapy and Research in Patients with Cancer 2022. [DOI: 10.1007/978-981-19-6710-8_7] [Reference Citation Analysis]
7 Cereda E, Tancredi R, Klersy C, Lobascio F, Crotti S, Masi S, Cappello S, Stobäus N, Tank M, Cutti S, Arcaini L, Bonzano E, Colombo S, Pedrazzoli P, Norman K, Caccialanza R. Muscle weakness as an additional criterion for grading sarcopenia-related prognosis in patients with cancer. Cancer Med 2021. [PMID: 34894098 DOI: 10.1002/cam4.4362] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Gil S, Jacob Filho W, Shinjo SK, Ferriolli E, Busse AL, Avelino-Silva TJ, Longobardi I, de Oliveira Júnior GN, Swinton P, Gualano B, Roschel H; HCFMUSP COVID-19 Study Group. Muscle strength and muscle mass as predictors of hospital length of stay in patients with moderate to severe COVID-19: a prospective observational study. J Cachexia Sarcopenia Muscle 2021;12:1871-8. [PMID: 34523262 DOI: 10.1002/jcsm.12789] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 14.0] [Reference Citation Analysis]
9 Yin L, Song C, Cui J, Wang N, Fan Y, Lin X, Zhang L, Zhang M, Wang C, Liang T, Ji W, Liu X, Li W, Shi H, Xu H; Investigation on Nutrition Status and Clinical Outcome of Common Cancers (INSCOC) Group. Low fat mass index outperforms handgrip weakness and GLIM-defined malnutrition in predicting cancer survival: Derivation of cutoff values and joint analysis in an observational cohort. Clin Nutr 2021;41:153-64. [PMID: 34883304 DOI: 10.1016/j.clnu.2021.11.026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
10 Yang M, Tan L, Xie L, Hu S, Liu D, Wang J, Li W. Factors That Improve Chest Computed Tomography-Defined Sarcopenia Prognosis in Advanced Non-Small Cell Lung Cancer. Front Oncol 2021;11:754975. [PMID: 34660324 DOI: 10.3389/fonc.2021.754975] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zhang X, Li X, Shi H, Zhang K, Zhang Q, Tang M, Li W, Zhou F, Liu M, Cong M, Shi H. Association of the fat-free mass index with mortality in patients with cancer: A multicenter observational study. Nutrition 2021;94:111508. [PMID: 34813982 DOI: 10.1016/j.nut.2021.111508] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
12 Zhang X, Zhang Q, Feng LJ, Zhang KP, Tang M, Song MM, Ruan GT, Zhang XW, Li W, Zhou FX, Cong MH, Shi HP. The Application of Fat-Free Mass Index for Survival Prediction in Cancer Patients With Normal and High Body Mass Index. Front Nutr 2021;8:714051. [PMID: 34422885 DOI: 10.3389/fnut.2021.714051] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Tanaka S, Ozeki N, Mizuno Y, Nakajima H, Hattori K, Inoue T, Nagaya M, Fukui T, Nakamura S, Goto M, Sugiyama T, Nishida Y, Chen-Yoshikawa TF. Preoperative paraspinous muscle sarcopenia and physical performance as prognostic indicators in non-small-cell lung cancer. J Cachexia Sarcopenia Muscle 2021;12:646-56. [PMID: 33665984 DOI: 10.1002/jcsm.12691] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
14 Langer D. Addressing the changing rehabilitation needs of patients undergoing thoracic surgery. Chron Respir Dis 2021;18:1479973121994783. [PMID: 33853343 DOI: 10.1177/1479973121994783] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Yin L, Zhang L, Li N, Guo J, Liu L, Lin X, Fan Y, Liu J, Zhang M, Chong F, Chen X, Wang C, Wang X, Liang T, Liu X, Deng L, Li W, Yang M, Yu J, Wang X, Liu X, Yang S, Zuo Z, Yuan K, Yu M, Song C, Cui J, Li S, Guo Z, Shi H, Xu H; Investigation on Nutrition Status and Clinical Outcome of Common Cancers (INSCOC) Group. Comparison of the AWGS and optimal stratification-defined handgrip strength thresholds for predicting survival in patients with lung cancer. Nutrition 2021;90:111258. [PMID: 33993045 DOI: 10.1016/j.nut.2021.111258] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Burtin C, Bezuidenhout J, Sanders KJC, Dingemans AC, Schols AMWJ, Peeters STH, Spruit MA, De Ruysscher DKM. The Authors reply: Comment on: "Handgrip weakness, low fat-free mass, and overall survival in non-small cell lung cancer treated with curative-intent radiotherapy" by Burtin et al. J Cachexia Sarcopenia Muscle 2021;12:526-7. [PMID: 33506627 DOI: 10.1002/jcsm.12672] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Nakano J, Fukushima T, Tanaka T, Fu JB, Morishita S. Physical function predicts mortality in patients with cancer: a systematic review and meta-analysis of observational studies. Support Care Cancer 2021;29:5623-34. [PMID: 33770257 DOI: 10.1007/s00520-021-06171-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
18 Voorn MJJ, Aerts LPA, Bootsma GP, Bezuidenhout JB, van Kampen-van den Boogaart VEM, Bongers BC, de Ruysscher DK, Janssen-Heijnen MLG. Associations of Pretreatment Physical Status Parameters with Tolerance of Concurrent Chemoradiation and Survival in Patients with Non-small Cell Lung Cancer. Lung 2021;199:223-34. [PMID: 33693986 DOI: 10.1007/s00408-021-00427-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Ezzatvar Y, Ramírez-Vélez R, Sáez de Asteasu ML, Martínez-Velilla N, Zambom-Ferraresi F, Izquierdo M, García-Hermoso A. Physical Function and All-Cause Mortality in Older Adults Diagnosed With Cancer: A Systematic Review and Meta-Analysis. J Gerontol A Biol Sci Med Sci 2021;76:1447-53. [PMID: 33421059 DOI: 10.1093/gerona/glaa305] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
20 Shafieesabet A, Doehner W. Comment on: "Handgrip weakness, low fat-free mass, and overall survival in nonsmall cell lung cancer treated with curative-intent radiotherapy" by Burtin et al. J Cachexia Sarcopenia Muscle 2020;11:1863-4. [PMID: 33340290 DOI: 10.1002/jcsm.12637] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
21 Willemsen ACH, Degens JHRJ, Baijens LWJ, Dingemans AC, Hoeben A, Hoebers FJP, De Ruysscher DKM, Schols AMWJ. Early Loss of Fat Mass During Chemoradiotherapy Predicts Overall Survival in Locally Advanced Squamous Cell Carcinoma of the Lung, but Not in Locally Advanced Squamous Cell Carcinoma of the Head and Neck. Front Nutr 2020;7:600612. [PMID: 33324671 DOI: 10.3389/fnut.2020.600612] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
22 Bland KA, Zopf EM, Harrison M, Ely M, Cormie P, Liu E, Dowd A, Martin P. Prognostic Markers of Overall Survival in Cancer Patients Attending a Cachexia Support Service: An Evaluation of Clinically Assessed Physical Function, Malnutrition and Inflammatory Status. Nutr Cancer 2021;73:1400-10. [PMID: 32757683 DOI: 10.1080/01635581.2020.1800765] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
23 Simcock R, Wright J. Beyond Performance Status. Clin Oncol (R Coll Radiol) 2020;32:553-61. [PMID: 32684503 DOI: 10.1016/j.clon.2020.06.016] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 9.7] [Reference Citation Analysis]
24 Laviano A, Calder PC, Schols A, Lonnqvist F, Bech M, Dorkhan M, Muscaritoli M. Targeted Medical Nutrition in Pre-Cachectic Patients with Non-Small-Cell Lung Cancer: A Subgroup Analysis. Nutr Cancer 2021;73:899-900. [PMID: 32519909 DOI: 10.1080/01635581.2020.1773873] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Burtin C, Bezuidenhout J, Sanders KJC, Dingemans AC, Schols AMWJ, Peeters STH, Spruit MA, De Ruysscher DKM. Handgrip weakness, low fat-free mass, and overall survival in non-small cell lung cancer treated with curative-intent radiotherapy. J Cachexia Sarcopenia Muscle 2020;11:424-31. [PMID: 32045108 DOI: 10.1002/jcsm.12526] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
26 Ferguson MK. Can Frailty and Sarcopenia Be Mitigated in Lung Resection Candidates? Difficult Decisions in Surgery: An Evidence-Based Approach 2020. [DOI: 10.1007/978-3-030-47404-1_10] [Reference Citation Analysis]